Cargando…
Population‐based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma
BACKGROUND: Pancreatic cancer surgery is increasingly regionalized in high‐volume centres. Provision of adjuvant chemotherapy in the same institution can place a burden on patients, whereas receiving adjuvant chemotherapy at a different institution closer to home may create disparities in care. This...
Autores principales: | Latchana, N., Davis, L., Coburn, N. G., Mahar, A., Liu, Y., Hammad, A., Kagedan, D., Elmi, M., Siddiqui, M., Earle, C. C., Hallet, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354229/ https://www.ncbi.nlm.nih.gov/pubmed/30734019 http://dx.doi.org/10.1002/bjs5.50115 |
Ejemplares similares
-
A56 DEVELOPMENT OF A PROGNOSTIC SURVIVAL MODEL FOR PATIENTS DIAGNOSED WITH PANCREATIC CANCER IN ONTARIO
por: James, P, et al.
Publicado: (2023) -
Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline
por: Biagi, James J., et al.
Publicado: (2023) -
Adjuvant chemo-radiation for gastric adenocarcinoma: an institutional experience
por: Aftimos, Philippe G, et al.
Publicado: (2010) -
Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021) -
Surgical resectability of pancreatic adenocarcinoma: CTA
por: Wong, Jimmie C., et al.
Publicado: (2009)